Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111269227A details a green, one-pot synthesis of indolizine derivatives, offering significant cost reduction in API manufacturing and eliminating toxic oxidants.
Patent CN109776529B reveals a green, catalyst-free route for 1,2-diketone imidazoles, offering cost reduction and scalable manufacturing for pharma intermediates.
Novel phase-transfer catalysis method enhances Vildagliptin purity and yield. Offers significant cost reduction in API manufacturing and supply chain reliability for global partners.
Patent CN108137587B details a novel electrochemical recycling process for Finerenone intermediates, offering significant cost reduction and scalability for API manufacturing.
Novel 9-step synthesis of (+) -Erogorgiaene using Pd catalysis. Reduces cost and improves scalability for pharmaceutical intermediates supply chains globally.
Novel chiral induction method for Ombitasvir core structure. Reduces steps and cost. Reliable supply chain for pharmaceutical intermediates.
Patent CN117603023B reveals metal-free photocatalytic deuteration. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN102260213B reveals a high-yield tolvaptan synthesis route. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Advanced chiral preparation method for Carfilzomib intermediate ensuring high purity and yield. Optimized for commercial scale-up and cost reduction in pharmaceutical intermediates manufacturing.
Discover patented homocamptothecin synthesis with enhanced stability and yield. Reliable supplier for high-purity antitumor pharmaceutical intermediates and cost-effective manufacturing.
Patent CN111362962A details a novel fluorinated norcantharidin derivative with enhanced anti-tumor activity. Discover scalable synthesis routes and supply chain advantages for pharmaceutical intermediates.
Patent CN111233931B details a novel Remdesivir synthesis using Lewis acid catalysis. Discover cost-effective, scalable manufacturing solutions for high-purity antiviral intermediates.
Patent CN111925334B reveals a metal-free route to 5H-1,4-benzodiazepines using air oxidation, offering significant cost reduction and supply chain reliability for API intermediates.
Patent CN103333171B reveals a high-yield, transition-metal-free synthesis for pyrrole[1,2-a]quinoxaline derivatives, offering cost-effective manufacturing solutions.
Patent CN108774190B details a high-yield multi-step synthesis for benzoxazepine derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN106916079A details high-purity carbon-13 methacetin synthesis. Enhances supply chain reliability and reduces manufacturing costs for diagnostic reagents globally.
Patent CN104844602A reveals a novel one-pot synthesis for Linagliptin intermediates, offering higher yields and purity for reliable pharmaceutical supply chains.
Novel solid-phase method for EGFR inhibitors. High purity, scalable route for anticancer drug discovery intermediates.
Novel recrystallization method for Dienogest achieving >99% purity and >85% yield. Optimized solvent system reduces waste and enhances supply chain stability for hormonal APIs.
Patent CN119409585B reveals a safer oseltamivir isomer synthesis. Discover cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.